Anti-oxidative therapy with oral dapsone improved hcv antibody positive annular elastolytic giant cell granuloma

Journal of Dermatology

Volumn 24, Issue 5, 1997, Pages 328-331

  Igawa, Ken ^a   Maruyama, Ryuji ^a   Katayama, Ichiro ^a   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Annular elaslolytic giant cell granuloma; Anti oxidant; Dapsone; HCV

Indexed keywords

DAPSONE; STEROID; SUNSCREEN;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CRYOTHERAPY; DRUG EFFICACY; GIANT CELL GRANULOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; SKIN BIOPSY; STEROID THERAPY; TOPICAL DRUG ADMINISTRATION;

EID: 0030917817     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1997.tb02799.x     Document Type: Article

References (16)

1. Hanke CW, Bailin PL, Roenigk HH: Annular elastolytic giant cell granuloma, J Am Acad Dermatol, 1:413-421, 1979.
2. Dowling GB, Wilson-Jones E: Atypical necrobiosis lipoidica of the face and scalp, Dermatologica, 135: 11-26, 1967.
3. Mehregan AH, Altman J: Meischer's granuloma of the face, Arch Dermatol, 107: 62-64, 1973.
4. O'Brien JP: Actinic granuloma, Arch Dermatol, 111: 460-466, 1975.
5. Kato H, Kitajima Y, Yaoita H: Annular elastlytic giant cell granuloma, J Dermatol, 18: 667-670, 1991.
6. Ishibashi A, Yokoyama A, Hirano K: Annular elastolytic giant cell granuloma occurring in covered areas, Dermatologica, 174: 293-297, 1987.
7. Schwarz TH, Lindlbauer R, Gschnait F: Annular elastolytic giant cell granuloma, J Cut Pathol, 10: 321-326, 1983.
8. Steiner A, Pehamberger H, Wolff K: Sulfone treatment of granuloma annulare, J Am Acad Dermatol, 13: 1004-1008, 1985.
9. Roberts DE, Curd JG: Sulfonamides as anti-inflammatory agents in the treatment of Wegener's granulomatosis, Arthritis & Rheumatism, 33: 1590-1593, 1990.
10. Maton PN, Allison DJ, Chadwick VS: Downhill esophageal varices and occlusion of superior and inferior vena cava due to a systemic venulitis, J Clin Gastroenterology, 7: 331-337, 1985.
11. Thuong-Nguyen V, Kaduce DP, Hendrix JD, Gammon WR, Zone JJ: Inhibition of neutrophil adherence to antibody by dapsone - A possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses, J Invest Dermatol, 100: 349-355, 1993.
12. Ismail G, Boxer LA, Allen JM, Baehner RL: Improvement of polymorphonuclear leucocyte oxidative and bactericidal functions in chronic granulomatous disease with 4-amino-4′-hydroxylaminodiphenyl sulfone, British Journal of Haematology, 40: 219-229, 1978.
13. Kettle AJ, Gedye CA, Winterbourn CC: Superoxide is an antagonist of antiinflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase, Biochemical Pharmacology, 45: 2003-2010, 1993.
14. Hearth-Holmes M, Zahradka SL, Baethage BA, Wolf RE: Leukocytoclastic vasculitis with hepatitis C, Am J Med, 90: 765-766, 1991.
15. Cribier B, Gamier C, Laustriat D, Heid E: Lichen planus and hepatitis C virus infection, J Am Acad Dermatol, 31: 1070-1072, 1994.
16. Georgeston MJ, Yartz JC, Lalos AT, Webster GF, Martin P: Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis, Am J Gastroenterology, 88: 1756-1758, 1993.